Get the app!
Back to Trades
Grant4

Moderna, Inc.

MRNA

Total Value
$99.2K

Company Information

Company Name
Moderna, Inc.
Ticker Symbol
MRNA
CIK
0001682852

Insider Information

Role
President
Officer
Location
CAMBRIDGE, MA

Filing Details

Filing Date
Feb 13, 2026
Transaction Date
Feb 11, 2026
Accession Number
0001682852-26-000019
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 11, 2026Common Stock4,884Grant/Award
Feb 11, 2026Common Stock2,362$41.99Tax Withholding$99.2K

Footnotes

  1. (F1)The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").
  2. (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.
  3. (F3)These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.